165 related articles for article (PubMed ID: 31509966)
1. E-cadherin Downregulation and microRNAs in Sporadic Intestinal-Type Gastric Cancer.
Rossi T; Tedaldi G; Petracci E; Abou Khouzam R; Ranzani GN; Morgagni P; Saragoni L; Monti M; Calistri D; Ulivi P; Molinari C
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31509966
[No Abstract] [Full Text] [Related]
2. Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer.
Carvalho J; van Grieken NC; Pereira PM; Sousa S; Tijssen M; Buffart TE; Diosdado B; Grabsch H; Santos MA; Meijer G; Seruca R; Carvalho B; Oliveira C
J Pathol; 2012 Sep; 228(1):31-44. PubMed ID: 22450781
[TBL] [Abstract][Full Text] [Related]
3. Expression level of microRNA-200c is associated with cell morphology in vitro and histological differentiation through regulation of ZEB1/2 and E-cadherin in gastric carcinoma.
Kurata A; Yamada M; Ohno SI; Inoue S; Hashimoto H; Fujita K; Takanashi M; Kuroda M
Oncol Rep; 2018 Jan; 39(1):91-100. PubMed ID: 29138864
[TBL] [Abstract][Full Text] [Related]
4. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
5. Digital PCR identifies changes in CDH1 (E-cadherin) transcription pattern in intestinal-type gastric cancer.
Abou Khouzam R; Molinari C; Salvi S; Marabelli M; Molinaro V; Orioli D; Saragoni L; Morgagni P; Calistri D; Ranzani GN
Oncotarget; 2017 Mar; 8(12):18811-18820. PubMed ID: 27861150
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer.
Ibarrola-Villava M; Llorca-Cardeñosa MJ; Tarazona N; Mongort C; Fleitas T; Perez-Fidalgo JA; Roselló S; Navarro S; Ribas G; Cervantes A
Oncotarget; 2015 Sep; 6(29):26935-45. PubMed ID: 26334097
[TBL] [Abstract][Full Text] [Related]
8. Plasma Level of MicroRNAs, MiR-107, MiR-194 and MiR-210 as Potential Biomarkers for Diagnosis Intestinal-Type Gastric Cancer in Human.
Parvaee P; Sarmadian H; Khansarinejad B; Amini M; Mondanizadeh M
Asian Pac J Cancer Prev; 2019 May; 20(5):1421-1426. PubMed ID: 31127902
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-126 increases chemosensitivity in drug-resistant gastric cancer cells by targeting EZH2.
Wang P; Li Z; Liu H; Zhou D; Fu A; Zhang E
Biochem Biophys Res Commun; 2016 Oct; 479(1):91-6. PubMed ID: 27622325
[TBL] [Abstract][Full Text] [Related]
10. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.
Graziano F; Arduini F; Ruzzo A; Mandolesi A; Bearzi I; Silva R; Muretto P; Testa E; Mari D; Magnani M; Scartozzi M; Cascinu S
Ann Oncol; 2004 Mar; 15(3):489-92. PubMed ID: 14998854
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of microRNA-200 in EBV-associated gastric carcinoma.
Shinozaki A; Sakatani T; Ushiku T; Hino R; Isogai M; Ishikawa S; Uozaki H; Takada K; Fukayama M
Cancer Res; 2010 Jun; 70(11):4719-27. PubMed ID: 20484038
[TBL] [Abstract][Full Text] [Related]
12. Plasma microRNA-103, microRNA-107, and microRNA-194 levels are not biomarkers for human diffuse gastric cancer.
Oze I; Shimada S; Nagasaki H; Akiyama Y; Watanabe M; Yatabe Y; Matsuo K; Yuasa Y
J Cancer Res Clin Oncol; 2017 Mar; 143(3):551-554. PubMed ID: 27909811
[TBL] [Abstract][Full Text] [Related]
13. miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression.
Xie J; Chen M; Zhou J; Mo MS; Zhu LH; Liu YP; Gui QJ; Zhang L; Li GQ
Oncol Rep; 2014 Apr; 31(4):1715-22. PubMed ID: 24573489
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-31 triggers G
Sun KK; Shen XJ; Yang D; Gan MQ; Liu G; Zhang YF; Hua P; Wang HD; Wu XY
Arch Biochem Biophys; 2019 Mar; 663():269-275. PubMed ID: 30677405
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.
Corso G; Carvalho J; Marrelli D; Vindigni C; Carvalho B; Seruca R; Roviello F; Oliveira C
J Clin Oncol; 2013 Mar; 31(7):868-75. PubMed ID: 23341533
[TBL] [Abstract][Full Text] [Related]
16. Association between the CDH1-472delA and -160C>A polymorphisms and diffuse and intestinal gastric cancer in a Mexican population.
Bustos-Carpinteyro AR; Delgado-Figueroa N; Santiago-Luna E; Magaña-Torres MT; Sánchez-López JY
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706737
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.
Zheng B; Liang L; Wang C; Huang S; Cao X; Zha R; Liu L; Jia D; Tian Q; Wu J; Ye Y; Wang Q; Long Z; Zhou Y; Du C; He X; Shi Y
Clin Cancer Res; 2011 Dec; 17(24):7574-83. PubMed ID: 21994419
[TBL] [Abstract][Full Text] [Related]
18. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.
Tang H; Deng M; Tang Y; Xie X; Guo J; Kong Y; Ye F; Su Q; Xie X
Clin Cancer Res; 2013 Oct; 19(20):5602-12. PubMed ID: 23995857
[TBL] [Abstract][Full Text] [Related]
19. NTRK2 is an oncogene and associated with microRNA-22 regulation in human gastric cancer cell lines.
Hu J; Huang Y; Wu Y; Liu F; Sun D; Wang K; Qu H
Tumour Biol; 2016 Nov; 37(11):15115-15123. PubMed ID: 27662840
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
